Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IXEKIZUMAB Cause Wrong technique in product usage process? 106 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Wrong technique in product usage process have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.3% of all adverse event reports for IXEKIZUMAB.

106
Reports of Wrong technique in product usage process with IXEKIZUMAB
0.3%
of all IXEKIZUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Wrong technique in product usage process From IXEKIZUMAB?

Of the 106 reports, 1 (0.9%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 106 reports have been filed with the FAERS database.

What Other Side Effects Does IXEKIZUMAB Cause?

Injection site pain (3,799) Psoriasis (2,818) Drug ineffective (2,759) Injection site erythema (2,144) Injection site reaction (1,701) Injection site swelling (1,615) Incorrect dose administered (1,032) Covid-19 (861) Product dose omission issue (832) Therapy interrupted (796)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which IXEKIZUMAB Alternatives Have Lower Wrong technique in product usage process Risk?

IXEKIZUMAB vs JAKAFI IXEKIZUMAB vs JANUMET IXEKIZUMAB vs JANUVIA IXEKIZUMAB vs JETREA IXEKIZUMAB vs JUXTAPID

Related Pages

IXEKIZUMAB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process IXEKIZUMAB Demographics